The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
Open accessAbstract
Ceftolozane/tazobactam and ceftazidime/avibactam are 2 novel β-lactam/β-lactamase combination antibiotics. The antimicrobial spectrum of activity of these antibiotics includes multidrug-resistant (MDR) gram-negative bacteria (GNB), including Pseudomonas aeruginosa. Ceftazidime/avibactam is also active against carbapenem-resistant Enterobacteriaceae that produce Klebsiella pneumoniae carbapenemases. However, avibactam does not inactivate metallo-β-lactamases such as New Delhi metallo-β-lactamases. Both ceftolozane/tazobactam and ceftazidime/avibactam are only available as intravenous formulations and are dosed 3 times daily in patients with normal renal function. Clinical trials showed noninferiority to comparators of both agents when used in the treatment of complicated urinary tract infections and complicated intra-abdominal infections (when used with metronidazole). Results from pneumonia studies have not yet been reported. In summary, ceftolozane/tazobactam and ceftazidime/avibactam are 2 new second-generation cephalosporin/β-lactamase inhibitor combinations. After appropriate trials are conducted, they may prove useful in the treatment of MDR GNB infections. Antimicrobial stewardship will be essential to preserve the activity of these agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Munoz-Price, L. S., Poirel, L., Bonomo, R. A., Schwaber, M. J., Daikos, G. L., Cormican, M., Cornaglia, G., Garau, J., Gniadkowski, M., Hayden, M. K., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70190-7 · Cited by 1,627
Self-citationBoucher, H. W., Talbot, G. H., Benjamin, D. K., Bradley, J., Guidos, R. J., Jones, R. N., Murray, B. E., Bonomo, R. A., Gilbert, D., & for the Infectious Diseases Society of America (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit152 · Cited by 700
Self-citationPaterson, D. L., Ko, W.-C., Von Gottberg, A., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K. P., Bonomo, R. A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/420816 · Cited by 571
Self-citationAvibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitor
Ehmann, D. E., Jahić, H., Ross, P. L., Gu, R.-F., Hu, J., Kern, G., Walkup, G. K., & Fisher, S. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205073109 · Cited by 545
Solomkin, J., Hershberger, E., Miller, B., Popejoy, M., Friedland, I., Steenbergen, J., Yoon, M., Collins, S., Yuan, G., Barie, P. S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ097 · Cited by 420
Mazuski, J. E., Gasink, L. B., Armstrong, J., Broadhurst, H., Stone, G. G., Rank, D., Llorens, L., Newell, P., & Pachl, J. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw133 · Cited by 393
Wagenlehner, F. M., Umeh, O., Steenbergen, J., Yuan, G., & Darouiche, R. O. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62220-0 · Cited by 388
Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes
van Duin, D., Kaye, K. S., Neuner, E. A., & Bonomo, R. A. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.11.009 · Cited by 352
Self-citationSader, H. S., Farrell, D. J., Flamm, R. K., & Jones, R. N. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.007 · Cited by 248
Lucasti, C., Popescu, I., Ramesh, M. K., Lipka, J., & Sable, C. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks523 · Cited by 234
Vazquez, J. A., González Patzán, L. D., Stricklin, D., Duttaroy, D. D., Kreidly, Z., Lipka, J., & Sable, C. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.748653 · Cited by 219
Farrell, D. J., Flamm, R. K., Sader, H. S., & Jones, R. N. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01802-13 · Cited by 203
Stachyra, T., Levasseur, P., Pechereau, M.-C., Girard, A.-M., Claudon, M., Miossec, C., & Black, M. T. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp197 · Cited by 180
The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam
Sorgel, F., & Kinzig, M. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.suppl_a.39 · Cited by 178
New Delhi Metallo-beta-lactamase around the world: An eReview using Google Maps
Berrazeg, M., Diene, S. M., Medjahed, L., Parola, P., Drissi, M., Raoult, D., & Rolain, J. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.20.20809 · Cited by 152
Sader, H. S., Farrell, D. J., Castanheira, M., Flamm, R. K., & Jones, R. N. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku184 · Cited by 149
Farrell, D. J., Sader, H. S., Flamm, R. K., & Jones, R. N. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.032 · Cited by 146
Winkler, M., Papp‐Wallace, K. M., Hujer, A. M., Domitrovic, T., Hujer, K. M., Hurless, K. N., Tuohy, M. J., Hall, G. S., & Bonomo, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04238-14 · Cited by 143
Self-citationCastanheira, M., Mills, J. C., Farrell, D. J., & Jones, R. N. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03681-14 · Cited by 141
Li, H., Estabrook, M. A., Jacoby, G. A., Nichols, W. W., TESTA, R. T., & Bush, K. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04191-14 · Cited by 130
Sader, H. S., Castanheira, M., Flamm, R. K., Farrell, D. J., & Jones, R. N. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02429-13 · Cited by 129
Andes, D. R., & Craig, W. A. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01265.x · Cited by 126
Castanheira, M., Mills, J. C., Costello, S. E., Jones, R. N., & Sader, H. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00163-15 · Cited by 123
Chandorkar, G., Huntington, J. A., Gotfried, M. H., Rodvold, K. A., & Umeh, O. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks246 · Cited by 118
LUCASTI, C. J., Hershberger, E., Miller, B. W., Yankelev, S., Steenbergen, J. N., Friedland, I. R., & Solomkin, J. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00049-14 · Cited by 114
Variants of β-Lactamase KPC-2 That Are Resistant to Inhibition by Avibactam
Papp‐Wallace, K. M., Winkler, M., Taracila, M. A., & Bonomo, R. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04406-14 · Cited by 105
Self-citationLevasseur, P., Girard, A.-M., Claudon, M., Goossens, H., Black, M. T., Coleman, K., & Miossec, C. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06064-11 · Cited by 102
Sader, H. S., Castanheira, M., Flamm, R. K., Mendes, R. E., Farrell, D. J., & Jones, R. N. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.02.022 · Cited by 89
Sader, H. S., Farrell, D. J., Flamm, R. K., & Jones, R. N. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.04.004 · Cited by 88
Sader, H. S., Castanheira, M., Mendes, R. E., Flamm, R. K., Farrell, D. J., & Jones, R. N. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05024-14 · Cited by 83
Flamm, R. K., Farrell, D. J., Sader, H. S., & Jones, R. N. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku025 · Cited by 70
Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin
Wise, R. A., Logan, M., Cooper, M., & Andrews, J. M. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1081 · Cited by 70
Walkty, A. J., DeCorby, M. R., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., & Zhanel, G. G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01696-10 · Cited by 65
Chandorkar, G., Xiao, A. J., Mouksassi, S., Hershberger, E., & Krishna, G. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.395 · Cited by 63
Tato, M., García-Castillo, M., Bofarull, A. M., & Cantón, R. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.07.004 · Cited by 63
Sutherland, C. A., & Nicolau, D. P. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.05.501 · Cited by 60
Flamm, R. K., Sader, H. S., Farrell, D. J., & Jones, R. N. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.07.005 · Cited by 50
Murano, K., Yamanaka, T., Toda, A., Ohki, H., Okuda, S., Kawabata, K., Hatano, K., Takeda, S., Akamatsu, H., Itoh, K., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.11.074 · Cited by 46
Walkty, A. J., Karlowsky, J. A., Adam, H. J., Baxter, M. R., Lagacé-Wiens, P. R. S., Hoban, D. J., & Zhanel, G. G. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01404-13 · Cited by 37
Sader, H. S., Castanheira, M., Farrell, D. J., Flamm, R. K., & Jones, R. N. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.06.008 · Cited by 34
Huband, M. D., Castanheira, M., Flamm, R. K., Farrell, D. J., Jones, R. N., & Sader, H. S. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03056-15 · Cited by 34
Estabrook, M. A., Bussell, B., Clugston, S. L., & Bush, K. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02357-14 · Cited by 26
Dubreuil, L. J., Mahieux, S., Neut, C., Miossec, C., & Pace, J. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.02.013 · Cited by 26
Cited by
The global epidemiology of carbapenemase-producing Enterobacteriaceae
van Duin, D., & Doi, Y. (2017) · Virulence · doi:10.1080/21505594.2016.1222343 · Cited by 1,004
Self-citationEpidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
Nordmann, P., & Poirel, L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz824 · Cited by 721
Rodríguez-Baño, J., Gutiérrez-Gutiérrez, B., Machuca, I., & Pascual, A. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00079-17 · Cited by 704
van Duin, D., Lok, J. J., Earley, M., Cober, E., Richter, S. S., Perez, F., Salata, R. A., Kalayjian, R. C., Watkins, R. R., Doi, Y., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix783 · Cited by 655
Self-citationNew β-Lactam–β-Lactamase Inhibitor Combinations
Yahav, D., Giske, C. G., Grāmatniece, A., Abodakpi, H., Tam, V. H., & Leibovici, L. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00115-20 · Cited by 521
Metadata
- Authors
- van Duin, D., & Bonomo, R. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-04-20
- Volume
- 63
- Issue
- 2
- Pages
- 234-241
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2339454548
- Cited by
- 549
- References
- 44
- FWCI
- 24.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.